Current safety data suggest that lamivudine, telbivudine, or tenofovir may be used during pregnancy. However, the timing in initiating antiviral therapy requires careful assessment of risks and ...

Merck, known as MSD outside the United States and Canada announced that the Food and Drug Administration (FDA) has approved two new HIV-1 medicines: Delstrigo and Pifeltro. The FDA has approved ...

In October 2013, Department of Health and Human Services (DHHS) guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents were updated to include the recommendation of ...

Failure of a regime containing emtricitabine is likely to lead to the emergence of the M184V mutation, causing high-level resistance to lamivudine and low-level resistance to abacavir. See Tenofovir ...